Table 1.
Characteristics of participants.
| Characteristics | (n = 1034) | |
|---|---|---|
| Mean±SD or n (%) | Median (Q1, Q3) | |
| Age, years | 64.8±8.6 | 64.9 (59.8, 70.5) |
| Women, n (%) | 729 (72.5) | |
| BMI, kg/m2 | 32.0±6.7 | 31 (27.4, 35.7) |
| Total cholesterol, mg/dL | 201±42 | 197.5 (172.5, 227) |
| HDL cholesterol, mg/dL | 57.5±17.9 | 55.2 (45, 66.8) |
| Systolic BP, mm Hg | 142±20 | 141 (128, 154) |
| Diastolic BP, mm Hg | 80±11 | 79 (72, 87) |
| Pulse pressure, mm Hg | 62±18 | 60 (50, 73) |
| Heart rate, bpm | 67±11 | 66 (59, 74) |
| eGFR, ml/min | 97.7±31.3 | 94.2 (77.2, 114.1) |
| Ever-smoker, n (%) | 418 (40.4) | - |
| Diabetes mellitus, n (%) | 346 (33.5) | - |
| Previous history of MI or stroke, n (%) | 135 (13.0) | - |
| BP-lowering medications, n (%) | 883 (85.4) | - |
| Beta-blocker, n (%) | 211 (20.4) | - |
| Calcium-channel blocker, n (%) | 367 (35.5) | - |
| Diuretic, n (%) | 585 (56.6) | - |
| RAAS inhibitor, n (%) | 506 (48.9) | - |
| Statin, n (%) | 222 (21.5) | - |
| Aspirin, n (%) | 371 (35.9) | - |
| MR-proADM, nmol/L | 0.60±0.23 | 0.55 (0.44, 0.72) |
| LVMi, g/m2.7 | 41.2±11.4 | 39.1 (33.7, 47.1) |
| UACR, mg/g | 57.3±208.8 | 6.9 (3.2, 20.8) |
*
Continuous variables are presented as mean ± standard deviation and inter-quartile range, whereas categorical variables are presented as counts and percentages.
‡
BMI, body mass index ; BP, blood pressure; eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein; LVMi, left ventricular mass index; MR-proADM, midregional pro-adrenomedullin; RAAS, renin-angiotensin-aldosterone system.